BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 47
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (12746)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.
Item 
Count 
PDF881
WORD324
HTML8300
Tables (1-4)335
 Sum=9840
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1248
Download1658
 Sum=2906
Dec 21, 2014 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20(47): 17932-17940 [PMID: 25548491 DOI: 10.3748/wjg.v20.i47.17932]
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17932.htm
Number Citing Articles
1
Julia Wattacheril, Arun J. Sanyal. Lean NAFLD: an Underrecognized Outlier. Current Hepatology Reports 2016; 15(2): 134 doi: 10.1007/s11901-016-0302-1
2
Asmaa S. Sieddek, Raghda Refaie Muhammed, Dina Attia. Screening of Metabolic-Associated Fatty Liver Disease in General Population Attending Outpatient Clinic. SN Comprehensive Clinical Medicine 2024; 6(1) doi: 10.1007/s42399-023-01628-4
3
Xia Fang, Hongya Wang, Ting Ye, Xiaolan Fu, Xiaozhen Tan, Yan Zeng, Jiahao Fan, Yong Xu. Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01518-5
4
Atsuko Nakatsuka, Makoto Matsuyama, Satoshi Yamaguchi, Akihiro Katayama, Jun Eguchi, Kazutoshi Murakami, Sanae Teshigawara, Daisuke Ogawa, Nozomu Wada, Tetsuya Yasunaka, Fusao Ikeda, Akinobu Takaki, Eijiro Watanabe, Jun Wada. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Scientific Reports 2016; 6(1) doi: 10.1038/srep21721
5
Nan Tang, Lei Ji, Xinyu Shi, Yalan Xiong, Xinying Xiong, Hanhua Zhao, Hualing Song, Jianying Wang, Lei Zhang, Shengfu You, Guang Ji, Baocheng Liu, Na Wu. Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics. Pharmaceuticals 2024; 17(4): 502 doi: 10.3390/ph17040502
6
Young Eun Chon, Hyung Jong Kim, Yu Bum Choi, Seong Gyu Hwang, Kyu Sung Rim, Mi Na Kim, Joo Ho Lee, Yeonjung Ha, Mi Jung Lee. Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65940-y
7
Z. Li, F. Sun, Z. Hu, J. Xiang, J. Zhou, S. Yan, J. Wu, L. Zhou, S. Zheng. New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database. Transplantation Proceedings 2016; 48(1): 138 doi: 10.1016/j.transproceed.2015.11.010
8
Shah Mohammad Fahim, Muhammad Abdul Baker Chowdhury, Shahinul Alam. Non-alcoholic fatty liver disease (NAFLD) among underweight adults. Clinical Nutrition ESPEN 2020; 38: 80 doi: 10.1016/j.clnesp.2020.06.002
9
Xingxing Zhang, Zhiying He, Qiya Si, Xiang Hu, Lijuan Yang, Xiao Gu, Linjia Du, Lei Wang, Linyu Pan, Yingqian Li, Jing Li, Bo Yang, Xuejiang Gu, Ferdinando Carlo Sasso. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research 2022; 2022: 1 doi: 10.1155/2022/2229139
10
Yuou Ying, Yuan Ji, Ruyi Ju, Jinhan Chen, Mingxian Chen. Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017–2020. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-024-03579-z
11
Mounir Ould Setti, Ari Voutilainen, Behnam Tajik, Leo Niskanen, Tomi-Pekka Tuomainen. Negative interaction of fatty liver and hypertension on cardiovascular mortality in non-diabetic men: 34 years of follow-up. Scandinavian Journal of Gastroenterology 2021; 56(9): 1096 doi: 10.1080/00365521.2021.1951836
12
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, Marco Rossato. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2019; 20(9): 2215 doi: 10.3390/ijms20092215
13
S. Sookoian, C. J. Pirola. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Alimentary Pharmacology & Therapeutics 2017; 46(2): 85 doi: 10.1111/apt.14112
14
Govardhan Bale, Ravikanth V. Vishnubhotla, Sasikala Mitnala, Mithun Sharma, Rao N. Padaki, Smita C. Pawar, Reddy N. Duvvur. Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2019; 9(5): 561 doi: 10.1016/j.jceh.2019.02.001
15
Praveen Kumar Conjeevaram Selvakumar, Mohammad Nasser Kabbany, Rocio Lopez, Maria S Rayas, Jane L Lynch, Naim Alkhouri. Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States. Journal of Pediatric Gastroenterology and Nutrition 2018; 67(1): 75 doi: 10.1097/MPG.0000000000001974
16
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal. Non-alcoholic fatty liver disease in lean individuals. JHEP Reports 2019; 1(4): 329 doi: 10.1016/j.jhepr.2019.08.002
17
Zobair Younossi, Linda Henry. Non-Alcoholic Fatty Liver Disease. 2020; : 15 doi: 10.1007/978-3-319-95828-6_2
18
Chunlong Li, Panpan Guo, Runan Zhang, Meng Zhang, Yanchuan Li, Min Huang, Xiaoning Ji, Yongshuai Jiang, Cheng Wang, Rui Li, Rennan Feng. Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population. Journal of Clinical Gastroenterology 2019; 53(6): e253 doi: 10.1097/MCG.0000000000001089
19
Moushira Zaki, Walaa Yousef, Sanaa Kamal, Ramy Mohamed, Omnia Saleh, Wafaa Ezzat. Association Between Metabolic Abnormalities and Non-Alcoholic Fatty Liver in Obese Premenopausal Women. Biomedical and Pharmacology Journal 2018; 11(2): 1161 doi: 10.13005/bpj/1477
20
Xinyu Huang, Yingcheng Yao, Xiaoli Hou, Li Wei, Yuhan Rao, Yu Su, Guo Zheng, Xiong Z. Ruan, Danyang Li, Yaxi Chen. Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING–NF-κB Signaling Pathway. Cellular and Molecular Gastroenterology and Hepatology 2022; 14(1): 1 doi: 10.1016/j.jcmgh.2022.03.006
21
Hui Zhao, Bin Hu. Risk Factors for Non-alcoholic Fatty Liver Disease in Chinese Population: A Five-year Follow-up Study. Iranian Red Crescent Medical Journal 2019; 21(7) doi: 10.5812/ircmj.91064
22
Jeong-Ju Yoo, Eun Ju Cho, Goh Eun Chung, Young Chang, Yuri Cho, Sang-Hyun Park, Su-Min Jeong, Bo-Yeon Kim, Dong Wook Shin, Yun Joon Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu. Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults. Journal of Clinical Medicine 2022; 11(4): 935 doi: 10.3390/jcm11040935
23
An Zhang, Xin Luo, Hong Pan, Xinxin Shen, Baocheng Liu, Dong Li, Jijia Sun. Establishment and evaluation of a risk-prediction model for hypertension in elderly patients with NAFLD from a health management perspective. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18718-3
24
Kentaro Oniki, Junji Saruwatari, Tomoko Izuka, Ayami Kajiwara, Kazunori Morita, Misaki Sakata, Koji Otake, Yasuhiro Ogata, Kazuko Nakagawa, Silvia C. Sookoian. Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects. PLOS ONE 2015; 10(7): e0132640 doi: 10.1371/journal.pone.0132640
25
Doaa Abdelmoneim, Mohamed El‐Adl, Gehad El‐Sayed, El Said El‐Sherbini. Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats. Fundamental & Clinical Pharmacology 2021; 35(2): 379 doi: 10.1111/fcp.12597
26
Xiuying Zhang, Xianghai Zhou, Xueyao Han, Zuodi Fu, Lianying Wang, Yufeng Li, Linong Ji. The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population. Metabolic Syndrome and Related Disorders 2020; 18(6): 284 doi: 10.1089/met.2019.0107
27
Ilkay S. Idilman, Hsien Min Low, Tolga Gidener, Kenneth Philbrick, Taofic Mounajjed, Jiahui Li, Alina M. Allen, Meng Yin, Sudhakar K. Venkatesh. Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2021; 10(12): 2565 doi: 10.3390/jcm10122565
28
M V Machado, G A Michelotti, M L Jewell, T A Pereira, G Xie, R T Premont, A M Diehl. Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. Cell Death & Disease 2016; 7(2): e2096 doi: 10.1038/cddis.2016.19
29
Anna Ludovica Fracanzani, Salvatore Petta, Rosa Lombardi, Giuseppina Pisano, Maurizio Russello, Dario Consonni, Vito Di Marco, Calogero Cammà, Laura Mensi, Paola Dongiovanni, Luca Valenti, Antonio Craxì, Silvia Fargion. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Clinical Gastroenterology and Hepatology 2017; 15(10): 1604 doi: 10.1016/j.cgh.2017.04.045
30
Guoqing Huang, Qiankai Jin, Yushan Mao. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study. Journal of Medical Internet Research 2023; 25: e46891 doi: 10.2196/46891
31
Dimitrios S Karagiannakis, George Markakis, Dimitra Lakiotaki, Evangelos Cholongitas, Jiannis Vlachogiannakos, George Papatheodoridis. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2022; 34(9): 961 doi: 10.1097/MEG.0000000000002412
32
Terence T. Lao. Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. Best Practice & Research Clinical Obstetrics & Gynaecology 2020; 68: 2 doi: 10.1016/j.bpobgyn.2020.02.011
33
Shou-Wu Lee, Teng-Yu Lee, Sheng-Shun Yang, Chun-Fang Tung, Hong-Zen Yeh, Chi-Sen Chang. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population. Hepatobiliary & Pancreatic Diseases International 2018; 17(1): 45 doi: 10.1016/j.hbpd.2018.01.007
34
Yebei Liang, Mao Ye, Xuhong Hou, Peizhu Chen, Li Wei, Fusong Jiang, Liang Feng, Lichang Zhong, Huaiyu Liu, Yuqian Bao, Weiping Jia. Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese. Diabetes Research and Clinical Practice 2020; 169: 108385 doi: 10.1016/j.diabres.2020.108385
35
Emilio González-Reimers, Javier López-Prieto, Geraldine Quintero-Platt, Ricardo Pelazas-González, M Remedios Alemán-Valls, Onán Pérez-Hernández, M José de-la-Vega-Prieto, M Angeles Gómez-Rodríguez, Candelaria Martín-González, Francisco Santolaria-Fernández. Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis. World Journal of Hepatology 2016; 8(1): 74-82 doi: 10.4254/wjh.v8.i1.74
36
Jianghua Zhou, Feng Zhou, Wenxin Wang, Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Lihua Zhu, Jingjing Cai, Hongliang Li. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 2020; 71(5): 1851 doi: 10.1002/hep.31150
37
Marta Borges-Canha, João Neves, Maria Silva, Fernando Mendonça, Telma Moreno, Sara Ribeiro, João Correa, Catarina Vale, Juliana Gonçalves, Helena Urbano Ferreira, Sara Gil-Santos, Vanessa Guerreiro, Ana Sande, Selma B. Souto, Jorge Pedro, Paula Freitas, Davide Carvalho. Waist-to-Hip Ratio and Inflammatory Parameters Are Associated with Risk of Non-Alcoholic Fatty Liver Disease in Patients with Morbid Obesity. Biomedicines 2022; 10(10): 2416 doi: 10.3390/biomedicines10102416
38
Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Endocrinology and Metabolism 2020; 35(1): 165 doi: 10.3803/EnM.2020.35.1.165
39
Chongyang Ma, Kai Yan, Zisong Wang, Qiuyun Zhang, Lianyin Gao, Tian Xu, Jiayang Sai, Fafeng Cheng, Yuqiong Du. The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. Bioengineered 2021; 12(1): 2187 doi: 10.1080/21655979.2021.1933302
40
Milian Chen, Ying Cao, Guang Ji, Li Zhang. Lean nonalcoholic fatty liver disease and sarcopenia. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1217249
41
Jae Ho Park, Hee-jae Kim, Aleum Han, Deuk-mo Kang, Sok Park. Effects of aerobic exercise training on the risk factors for liver diseases in elderly women with obesity and impaired fasting glucose: A pilot study. Journal of Exercise Nutrition & Biochemistry 2019; 23(1): 21 doi: 10.20463/jenb.2019.0004
42
Tushar Prabhakar, Manya Prasad, Guresh Kumar, Kanica Kaushal, Priyanka S. Shenoy, Shantanu Dubey, Shiv Kumar Sarin. High prevalence of MAFLD in general population: A large cross‐sectional study calls for concerted public health action. Alimentary Pharmacology & Therapeutics 2024; 59(7): 843 doi: 10.1111/apt.17892
43
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Kourosh Kazemi, Alireza Shamsaeefar, Seyed Ali Malek-Hosseini. Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 572 doi: 10.1016/j.clinre.2019.09.002
44
M. E. Statsenko, A. M. Streltsova, M. V. Derevyanchenko. Fixed combination of ramipril and indapamide in patients with hypertension and non-alcoholic fatty liver disease: focus on the large arteries. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 2021; 27(3): 365 doi: 10.18705/1607-419X-2021-27-3-365-375
45
Phunchai Charatcharoenwitthaya, Khemajira Karaketklang, Wichai Aekplakorn. Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease. Journal of Cachexia, Sarcopenia and Muscle 2022; 13(5): 2393 doi: 10.1002/jcsm.13001
46
Niki S. Kakouri, Costas G. Thomopoulos, Eirini P. Siafi, Angeliki E. Valatsou, Kyriakos S. Dimitriadis, Iliana P. Mani, Sotirios P. Patsilinakos, Dimitrios M. Tousoulis, Konstantinos P. Tsioufis. Overview of the Association between Non-Alcoholic Fatty Liver Disease and Hypertension. Cardiology Discovery 2023;  doi: 10.1097/CD9.0000000000000113
47
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Burhanuddin Sohail Rangwala. Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241274310
48
Qiuhong Liu, Han Li, Weiwei He, Qing Zhao, Caoxin Huang, Qingxuan Wang, Zeyu Zheng, Xiaofang Zhang, Xiulin Shi, Xuejun Li. Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1075986
49
Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, Narendra Singh Choudhary, José Carlos Fernández-García, Bruno Ramos-Molina. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines 2021; 9(10): 1346 doi: 10.3390/biomedicines9101346
50
Lourianne Nascimento CAVALCANTE, Maria Gabriela Fernandes DEZAN, Cláudio Luiz da S L PAZ, André Castro LYRA. RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2022;  doi: 10.1590/s0004-2803.202204000-93
51
Qian Zhao, Xinyue Tang, Jiansheng Wu. The association between nonalcoholic fatty liver disease and metabolic comorbidities. Hepatology 2018; 67(6): 2474 doi: 10.1002/hep.29741
52
K.-C. Sung, D.-C. Seo, S.-J. Lee, M.-Y. Lee, S.H. Wild, C.D. Byrne. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(5): 489 doi: 10.1016/j.numecd.2019.01.016
53
Xixi Han, Jingwen Kong, Hemin Zhang, Yuan Zhao, Yafeng Zheng, Chao Wei. Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels. Obesity Facts 2024; 17(2): 191 doi: 10.1159/000536447
54
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
55
Hao Han, Yan Chen, Siqi Zhang, Xiaojuan Ji, Mingli Zhu, Wanyu Ma, Hongfeng Ge, Hailiang Chu. Association between serum ferritin and liver stiffness in adults aged ≥20 years: A cross-sectional study based on NHANES. Medicine 2023; 102(35): e34838 doi: 10.1097/MD.0000000000034838
56
Gurmehr Brar, Hidekazu Tsukamoto. Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science. Journal of Gastroenterology 2019; 54(3): 218 doi: 10.1007/s00535-018-01542-w
57
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
58
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. Clinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
59
Yanju Miao, Hong Tao. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study. BMJ Open 2023; 13(5): e069440 doi: 10.1136/bmjopen-2022-069440
60
Chunlong Li, Panpan Guo, Akinkunmi Paul Okekunle, Xiaoning Ji, Min Huang, Jiayue Qi, Yongshuai Jiang, Rennan Feng, Rui Li. Lean non‐alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non‐alcoholic fatty liver disease patients. Journal of Gastroenterology and Hepatology 2019; 34(1): 256 doi: 10.1111/jgh.14360
61
Mohammad Hossein Dabbaghmanesh, Farideh Danafar, Ahad Eshraghian, Gholamhossein Ranjbar Omrani. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(4): 513 doi: 10.1016/j.dsx.2018.03.006
62
Moein Ala, Seyed Parsa Eftekhar. Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective. Obesity Reviews 2023; 24(6) doi: 10.1111/obr.13563
63
Johanna K. DiStefano, Glenn S. Gerhard. NAFLD in normal weight individuals. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00814-z
64
Qi Xie, Shuqing Gao, Min Lei, Zengning Li. Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease. Aging 2022; 14(3): 1265 doi: 10.18632/aging.203817
65
Kaliyaperumal Kalaiyarasi, Acharyya Sanchalika, Low Hsien Min, Yap Wei Ming, Shelat Vishalkumar, Yew Kuo Chao, Low Jee Keem, Junnarkar Sameer, Huey Cheong Wei Terence, Tan Yen Ping. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study. Medicina 2024; 60(1): 169 doi: 10.3390/medicina60010169
66
Jingjing Cai, Xiao-Jing Zhang, Yan-Xiao Ji, Peng Zhang, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. Circulation Research 2020; 126(5): 679 doi: 10.1161/CIRCRESAHA.119.316337
67
Masoumeh Akhlaghi. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids. Phytotherapy Research 2016; 30(10): 1559 doi: 10.1002/ptr.5667
68
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
69
Chao Yang, Shujuan Yang, Weiwei Xu, Junhui Zhang, Wenguang Fu, Chunhong Feng, Giovanni Targher. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. PLOS ONE 2017; 12(5): e0177249 doi: 10.1371/journal.pone.0177249
70
Qing Song, Rui Guo, Wei Wei, Lin Lv, Zhenfeng Song, Renan Feng, Songtao Li, Changhao Sun. Histidine-alleviated hepatocellular death in response to 4-hydroxynonenal contributes to the protection against high-fat diet-induced liver injury. Journal of Functional Foods 2017; 39: 74 doi: 10.1016/j.jff.2017.09.056
71
Ryotaro Bouchi, Takato Takeuchi, Momoko Akihisa, Norihiko Ohara, Yujiro Nakano, Rie Nishitani, Masanori Murakami, Tatsuya Fukuda, Masamichi Fujita, Isao Minami, Masatomo Mihara, Takanobu Yoshimoto, Yoshihiro Ogawa. Increased visceral adiposity with normal weight is associated with the prevalence of non‐alcoholic fatty liver disease in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation 2016; 7(4): 607 doi: 10.1111/jdi.12443
72
Narendra S. Choudhary, Neeraj Saraf, Sanjiv Saigal, Ajay Duseja, Dheeraj Gautam, Amit Rastogi, Prashant Bhangui, Srinivasan Thiagrajan, Arvinder S. Soin. Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors. Journal of Clinical and Experimental Hepatology 2021; 11(5): 544 doi: 10.1016/j.jceh.2021.01.004
73
Nso Nso, Damla Mergen, Mashaal Ikram, Victor Macrinici, Kifah Hussain, Kevin Lee, Derek Ugwendum, Mia Trimingham, Senthil Balasubramanian, Riya Sam, Basile Njei. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis. Current Problems in Cardiology 2024; 49(6): 102569 doi: 10.1016/j.cpcardiol.2024.102569
74
Helda Tutunchi, Fatemeh Naeini, Majid Mobasseri, Alireza Ostadrahimi. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clinical Nutrition ESPEN 2021; 44: 483 doi: 10.1016/j.clnesp.2021.04.025
75
Ruohui Xu, Jiashu Pan, Wenjun Zhou, Guang Ji, Yanqi Dang. Recent advances in lean NAFLD. Biomedicine & Pharmacotherapy 2022; 153: 113331 doi: 10.1016/j.biopha.2022.113331
76
Stergios Kechagias, Patrik Nasr, Julia Blomdahl, Mattias Ekstedt. Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. Metabolism 2020; 111: 154183 doi: 10.1016/j.metabol.2020.154183
77
Wei Wu, Hongxi Zhang, Xiaoqin Xu, Ke Huang, Junfen Fu. Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children. International Journal of Endocrinology 2016; 2016: 1 doi: 10.1155/2016/4890974
78
Charlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, Alexanne Cuillerier, Marine De Loof, Marie-Ève Higgins, Hugues Boël, Caroline Daneault, Billie Chouinard, Marie-Élaine Clavet, Nolwenn Tessier, Isabelle Croteau, Geneviève Chabot, Catherine Martel, Martin G. Sirois, Sylvie Lesage, Yan Burelle, Matthieu Ruiz. A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis. Communications Biology 2024; 7(1) doi: 10.1038/s42003-024-06035-6
79
Kentaro Oniki, Junji Saruwatari. A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics. YAKUGAKU ZASSHI 2019; 139(1): 53 doi: 10.1248/yakushi.18-00163-3
80
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson, Thomas Jensen. Lean NAFLD: an underrecognized and challenging disorder in medicine. Reviews in Endocrine and Metabolic Disorders 2021; 22(2): 351 doi: 10.1007/s11154-020-09621-1
81
Omar T. Ahmed, Tolga Gidener, Kristin C. Mara, Joseph J. Larson, Terry M. Therneau, Alina M. Allen. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. Clinical Gastroenterology and Hepatology 2022; 20(6): 1374 doi: 10.1016/j.cgh.2021.07.016
82
Yan-Ci Zhao, Guo-Jun Zhao, Ze Chen, Zhi-Gang She, Jingjing Cai, Hongliang Li. Nonalcoholic Fatty Liver Disease. Hypertension 2020; 75(2): 275 doi: 10.1161/HYPERTENSIONAHA.119.13419
83
Ann Margaret C. Navarroza, Stephen N. Wong. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. Indian Journal of Gastroenterology 2021; 40(4): 380 doi: 10.1007/s12664-021-01184-6
84
Chun Pei, Chung-Ze Wu, Chang-Hsun Hsieh, Jin-Biou Chang, Yao-Jen Liang, Yen-Lin Chen, Dee Pei, Jiunn-Diann Lin. Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals. Metabolic Syndrome and Related Disorders 2019; 17(9): 458 doi: 10.1089/met.2019.0032
85
Fang-Zhou Ye, Wen-Yue Liu, Kenneth I. Zheng, Xiao-Yan Pan, Hong-Lei Ma, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(1): 80 doi: 10.1097/MEG.0000000000001483
86
Shuping Ruan, Xiaoqing Yuan, Juan Liu, Qing Zhang, Xinhua Ye. Predictors of High Cardiovascular Risk Among Nonobese Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease in a Chinese Population. Diabetes, Metabolic Syndrome and Obesity 2024; : 493 doi: 10.2147/DMSO.S441641
87
Linda Henry, James Paik, Zobair M. Younossi. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world. Alimentary Pharmacology & Therapeutics 2022; 56(6): 942 doi: 10.1111/apt.17158
88
Robert Skopec  Dubnik. Agriculture As Producer of World Cancer Epidemic. MOJ Biology and Medicine 2017; 1(6) doi: 10.15406/mojbm.2017.01.00034
89
Mingxing Chang, Zhihao Shao, Guifang Shen. Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants. BMJ Open 2023; 13(5): e070189 doi: 10.1136/bmjopen-2022-070189
90
Johanna K. DiStefano, Glenn S. Gerhard. Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index. Current Opinion in Gastroenterology 2023; 39(3): 156 doi: 10.1097/MOG.0000000000000920
91
David Højland Ipsen, Pernille Tveden‐Nyborg, Jens Lykkesfeldt. Normal weight dyslipidemia: Is it all about the liver?. Obesity 2016; 24(3): 556 doi: 10.1002/oby.21443
92
Ziyin Zhang, Lu Zhang, Wangyan Jiang, Tingting Du, Gang Yuan. Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients. Cardiovascular Diabetology 2022; 21(1) doi: 10.1186/s12933-022-01648-9
93
Georg Semmler, Sarah Wernly, Sebastian Bachmayer, Bernhard Wernly, Lena Schwenoha, Ursula Huber-Schönauer, Felix Stickel, David Niederseer, Elmar Aigner, Christian Datz. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk—A Single-Center Cross-Sectional Study. Clinical and Translational Gastroenterology 2021; 12(4): e00326 doi: 10.14309/ctg.0000000000000326
94
Hanako Nakajima, Hiroshi Okada, Masahide Hamaguchi, Kazushiro Kurogi, Hiroaki Murata, Masato Ito, Michiaki Fukui. Low aspartate aminotransferase/alanine aminotransferase ratio is a predictor of diabetes incidence in Japanese people: Population‐based Panasonic cohort study 5. Diabetes/Metabolism Research and Reviews 2022; 38(6) doi: 10.1002/dmrr.3553
95
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton, Tinsay A. Woreta. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2021; 50(1): 217 doi: 10.1016/j.gtc.2020.10.013
96
Sunyoung Lee, Kyoung Won Kim, Jeongjin Lee, Taeyong Park, Seungwoo Khang, Heeryeol Jeong, Gi‐Won Song, Sung‐Gyu Lee. Visceral adiposity as a risk factor for lean non‐alcoholic fatty liver disease in potential living liver donors. Journal of Gastroenterology and Hepatology 2021; 36(11): 3212 doi: 10.1111/jgh.15597
97
Curtis K Argo, Zachary H Henry. Editorial: “Lean” NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?. American Journal of Gastroenterology 2017; 112(1): 111 doi: 10.1038/ajg.2016.527
98
Hongbin Shi, Xiaoyan Guo, Qing Zhang, Hongmei Wu, Huanmin Du, Li Liu, Chongjin Wang, Yang Xia, Xing Liu, Chunlei Li, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Honglin Zhao, Kun Song, Dianjun Wei, Kaijun Niu, Massimo Pietropaolo. Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study. PLOS ONE 2015; 10(4): e0124255 doi: 10.1371/journal.pone.0124255
99
Nan Lu, Chang Shan, Jia-Rong Fu, Yi Zhang, Yu-Ying Wang, Yu-Chen Zhu, Jie Yu, Jie Cai, Sheng-Xian Li, Tao Tao, Wei Liu. RANKL Is Independently Associated with Increased Risks of Non-Alcoholic Fatty Liver Disease in Chinese Women with PCOS: A Cross-Sectional Study. Journal of Clinical Medicine 2023; 12(2): 451 doi: 10.3390/jcm12020451
100
Pinar Hamurcu Varol, Eda Kaya, Emel Alphan, Yusuf Yilmaz. Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. European Journal of Gastroenterology & Hepatology 2020; 32(10): 1352 doi: 10.1097/MEG.0000000000001656
101
Pirjo Käkelä, Tuomo Rantanen, Hannu Paajanen, Kirsi A Virtanen. Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report. Journal of Surgical Case Reports 2021; 2021(6) doi: 10.1093/jscr/rjab247
102
Yiwen Shi, Qianyi Wang, Yameng Sun, Xinyan Zhao, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Shanshan Wu, Hong You. The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2020; 54(4): 378 doi: 10.1097/MCG.0000000000001270
103
Julia A. Golubeva, Anna F. Sheptulina, Anastasia Yu. Elkina, Ekaterina O. Liusina, Anton R. Kiselev, Oxana M. Drapkina. Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?. Biomedicines 2023; 11(9): 2465 doi: 10.3390/biomedicines11092465
104
Gourdas Choudhuri, Saumin Shah, Anand Kulkarni, Nitin Jagtap, Pratyusha Gaonkar, Akshay Desai, Charles Adhav. Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions. Cureus 2023;  doi: 10.7759/cureus.42852
105
Yipeng Cheng, Kewei Zhang, Yang Chen, Yanchuan Li, Yuzheng Li, Kuang Fu, Rennan Feng. Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by 1H-MRS and Dual-Echo MRI. Nutrients 2016; 8(9): 527 doi: 10.3390/nu8090527
106
Ehimen C. Aneni, Marcio Sommer Bittencourt, Catherine Teng, Miguel Cainzos-Achirica, Chukwuemeka U. Osondu, Ahmed Soliman, Mouaz Al-Mallah, Matthew Buddoff, Edison R. Parise, Raul D. Santos, Khurram Nasir. The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study. American Journal of Preventive Cardiology 2020; 4: 100097 doi: 10.1016/j.ajpc.2020.100097
107
Steven Young, Raseen Tariq, John Provenza, Sanjaya K. Satapathy, Kamal Faisal, Abhijit Choudhry, Scott L. Friedman, Ashwani K. Singal. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis. Hepatology Communications 2020; 4(7): 953 doi: 10.1002/hep4.1519
108
Rimkyo Yeo, So Ra Yoon, Oh Yoen Kim. The Association between Food Group Consumption Patterns and Early Metabolic Syndrome Risk in Non-Diabetic Healthy People. Clinical Nutrition Research 2017; 6(3): 172 doi: 10.7762/cnr.2017.6.3.172
109
Saioa Gómez-Zorita, Maite Queralt, Maria Angeles Vicente, Marcela González, María P. Portillo. Metabolically healthy obesity and metabolically obese normal weight: a review. Journal of Physiology and Biochemistry 2021; 77(1): 175 doi: 10.1007/s13105-020-00781-x
110
Jia-Zhen ZHU, Hong-Wei YI, Wei HUANG, Tao PANG, Hui-Ping ZHOU, Xu-Dong WU. Fatty liver diseases, mechanisms, and potential therapeutic plant medicines. Chinese Journal of Natural Medicines 2020; 18(3): 161 doi: 10.1016/S1875-5364(20)30017-0
111
Ru Zhang, Minxian Wang, Min Wang, Liuxin Zhang, Yajie Ding, Zongzhe Tang, Zuqiang Fu, Haozhi Fan, Wei Zhang, Jie Wang. Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.648844
112
Ningjian Wang, Hualing Zhai, Bing Han, Qin Li, Yi Chen, Yingchao Chen, Fangzhen Xia, Dongping Lin, Yingli Lu. Visceral fat dysfunction is positively associated with hypogonadism in Chinese men. Scientific Reports 2016; 6(1) doi: 10.1038/srep19844
113
Linda Ban, Nicholas Shackel, Susan McLennan. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(3): 376 doi: 10.3390/ijms17030376
114
Walee Chamulitrat, Gerhard Liebisch, Anita Pathil, Wolfgang Stremmel. Dietary Interventions in Liver Disease. 2019; : 239 doi: 10.1016/B978-0-12-814466-4.00020-3
115
Yu-Ming Cheng, Jia-Horng Kao, Chia-Chi Wang. The metabolic profiles and body composition of lean metabolic associated fatty liver disease. Hepatology International 2021; 15(2): 405 doi: 10.1007/s12072-021-10147-0
116
Julia Fitzinger, Giovanny Rodriguez-Blanco, Markus Herrmann, Andrea Borenich, Rudolf Stauber, Elmar Aigner, Harald Mangge. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(2): 250 doi: 10.3390/nu16020250
117
Gourdas Choudhuri, Seema R Kalel, Zubin Dev Sharma, Rinkesh Bansal . MASLD- Global prevalence, pathophysiological processes and management pathways- tackling a complex problem. Gastroenterology & Hepatology: Open access 2024; 15(4): 74 doi: 10.15406/ghoa.2024.15.00585
118
Xue Wang, Jinlong You, Jing Tang, Xiuqian Li, Rui Wang, Yuanyuan Li, Yana Bai, Minzhen Wang, Shan Zheng. Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74841-3
119
Yang Chen, Rennan Feng, Xue Yang, Jiaxing Dai, Min Huang, Xiaoning Ji, Yong Li, Akinkunmi Paul Okekunle, Guanghui Gao, Justina Ucheojor Onwuka, Xiuyu Pang, Cheng Wang, Chunlong Li, Ying Li, Changhao Sun. Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. The American Journal of Clinical Nutrition 2019; 109(6): 1611 doi: 10.1093/ajcn/nqy358
120
Xiaoyin Huang, Yuchen Zeng, Mingyang Ma, Liangguang Xiang, Qingdan Liu, Ling Xiao, Ruimei Feng, Wanxin Li, Xiaoling Zhang, Moufeng Lin, Zhijian Hu, Hongwei Zhao, Shanshan Du, Weimin Ye. Associations between body composition profile and hypertension in different fatty liver phenotypes. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1247110
121
Rennan Feng, Chao Luo, Chunlong Li, Shanshan Du, Akinkunmi Paul Okekunle, Yanchuan Li, Yang Chen, Tianqi Zi, Yucun Niu. Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0551-1
122
Ramy Younes, Olivier Govaere, Salvatore Petta, Luca Miele, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Maria Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Anna Ludovica Fracanzani, Rocio Aller, Chiara Rosso, Javier Ampuero, Rocío Gallego-Durán, Angelo Armandi, Gian Paolo Caviglia, Marco Y W Zaki, Antonio Liguori, Paolo Francione, Grazia Pennisi, Antonio Grieco, Giovanni Birolo, Piero Fariselli, Mohammed Eslam, Luca Valenti, Jacob George, Manuel Romero-Gómez, Quentin Mark Anstee, Elisabetta Bugianesi. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?. Gut 2022; 71(2): 382 doi: 10.1136/gutjnl-2020-322564
123
Shuxia Shen, Hangkai Huang, Jinghua Wang, Zexi Tang, Chao Shen, Chengfu Xu. Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults. Digestive Diseases and Sciences 2023; 68(2): 656 doi: 10.1007/s10620-022-07787-z
124
Diana Buzova, Andrea Maugeri, Antonio Liguori, Cecilia Napodano, Oriana Lo Re, Jude Oben, Anna Alisi, Antonio Gasbarrini, Antonio Grieco, Jan Cerveny, Luca Miele, Manlio Vinciguerra. Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD). Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00917-2
125
Chun-Wei Lee, Chun-Ho Yun, Wen-Hung Huang, Ta-Chuan Hung, Cheng-Ting Tsai, Jen-Yuan Kuo, Cheng-Huang Su, Han-En Cheng, Chung-Lieh Hung, Charles Jia-Yin Hou. The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18499-9
126
Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher Donald Stave, Tetsuya Hosaka, Ramsey C Cheung, Mindie H Nguyen. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2020; 5(8): 739 doi: 10.1016/S2468-1253(20)30077-7
127
Ines Bilic-Curcic, Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Anna Mrzljak. Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals . World Journal of Hepatology 2021; 13(1): 80-93 doi: 10.4254/wjh.v13.i1.80
128
M. E. Statsenko, A. M. Streltsova. Metabolic effects of ramipril and indapamide in hypertensive patients with non-alcoholic fatty liver disease. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 2021; 27(4): 472 doi: 10.18705/1607-419X-2021-27-4-472-481
129
Pegah Golabi, James Paik, Natsu Fukui, Cameron T. Locklear, Leyla de Avilla, Zobair M. Younossi. Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality. Clinical Diabetes 2019; 37(1): 65 doi: 10.2337/cd18-0026
130
Meiling Li, Weiping Zhang, Xiude Li, Shaoxian Liang, Yaozong Zhang, Yufeng Mo, Songxian Rao, Honghua Zhang, Yong Huang, Yu Zhu, Zhuang Zhang, Wanshui Yang. Metabolic and Risk Profiles of Lean and Non-Lean Hepatic Steatosis among US Adults. Nutrients 2023; 15(13): 2856 doi: 10.3390/nu15132856
131
Madunil Anuk Niriella, A. Kasturiratne, A. Pathmeswaran, S. T. De Silva, K. R. Perera, S. K. C. E. Subasinghe, S. K. Kodisinghe, T. A. C. L. Piyaratna, K. Vithiya, A. S. Dassanayaka, A. P. De Silva, A. R. Wickramasinghe, F. Takeuchi, N. Kato, H. J. de Silva. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka. Hepatology International 2019; 13(3): 314 doi: 10.1007/s12072-018-9916-4
132
Bokun Kim, Keisuke Taniguchi, Tomonori Isobe, Sechang Oh. Triglyceride-glucose index is capable of identifying metabolically obese, normal-weight older individuals. Journal of Physiological Anthropology 2024; 43(1) doi: 10.1186/s40101-024-00355-6
133
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
134
Chileka Chiyanika, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Steve C. N. Hui, David K. W. Yeung, Winnie C. W. Chu. Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study. Clinical and Translational Gastroenterology 2021; 12(2): e00300 doi: 10.14309/ctg.0000000000000300
135
Emir Muzurović, Carol Chiung-Hui Peng, Matthew J. Belanger, Despina Sanoudou, Dimitri P. Mikhailidis, Christos S. Mantzoros. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. Hypertension 2022; 79(7): 1319 doi: 10.1161/HYPERTENSIONAHA.122.17982
136
Liyan Wang, Jiali Xu, Ningning You, Li Shao, Zhenjie Zhuang, Lili Zhuo, Jing Liu, Junping Shi. Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features. Lipids 2024; 59(6): 193 doi: 10.1002/lipd.12410
137
Ran Lu, Ye Liu, Tianpei Hong. Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review. Diabetes, Obesity and Metabolism 2023; 25(S1): 13 doi: 10.1111/dom.15014
138
Walee Chamulitrat, Chutima Jansakun, Huili Li, Gerhard Liebisch. Rescue of Hepatic Phospholipid Remodeling Defect in iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver. Biomolecules 2020; 10(9): 1332 doi: 10.3390/biom10091332
139
Hannah Mathew, Olivia M. Farr, Christos S. Mantzoros. Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism 2016; 65(1): 73 doi: 10.1016/j.metabol.2015.10.019
140
Fangyuan Cong, Luying Zhu, Lihua Deng, Qian Xue, Jingtong Wang. Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02708-4
141
Hiroaki Itoh, Naohiro Kanayama. Developmental Origins of Health and Disease (DOHaD). Advances in Experimental Medicine and Biology 2018; 1012: 29 doi: 10.1007/978-981-10-5526-3_4
142
Jia Xiao, Fei Wang, Nai-Kei Wong, Jinhan He, Rui Zhang, Ruijuan Sun, Yanying Xu, Yingxia Liu, Wei Li, Kazuo Koike, Weiling He, Hong You, Yinglei Miao, Xiaowei Liu, Mingming Meng, Bin Gao, Hua Wang, Cui Li. Global liver disease burdens and research trends: Analysis from a Chinese perspective. Journal of Hepatology 2019; 71(1): 212 doi: 10.1016/j.jhep.2019.03.004
143
Hai-lin Wang, Hui Zhang, Shang-ling Wu, Gong-cheng Liao, Ai-ping Fang, Ming-fan Zhu, Hui-lian Zhu, Sheng-Nan Lu. Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease. PLOS ONE 2017; 12(2): e0172027 doi: 10.1371/journal.pone.0172027
144
Qingdan Liu, Meilan Han, Meilan Li, Xiaoyin Huang, Ruimei Feng, Wanxin Li, Jun Chen, Haiying He, Wenxin Zheng, Zhijian Hu, Shanshan Du, Weimin Ye. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01947-4
145
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03315-0
146
María Teresa Julián, Ingrid Arteaga, Pere Torán-Monserrat, Guillem Pera, Alejandra Pérez-Montes de Oca, Irene Ruiz-Rojano, Elena Casademunt-Gras, Carla Chacón, Nuria Alonso. The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study. Nutrients 2024; 16(11): 1586 doi: 10.3390/nu16111586
147
Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis. Biomedicines 2021; 9(12): 1890 doi: 10.3390/biomedicines9121890
148
Wenting Wang, Jianping Ren, Wenzhao Zhou, Jinyu Huang, Guomin Wu, Fenfang Yang, Shuang Yuan, Juan Fang, Jing Liu, Yao Jin, Haiyang Qi, Yuyang Miao, Yanna Le, Cenhong Ge, Xiantao Qiu, JinJing Wang, Ping Huang, Zixin Liu, Sheng Wang. Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14701-0
149
Wai-Kay Seto, Man-Fung Yuen. Nonalcoholic fatty liver disease in Asia: emerging perspectives. Journal of Gastroenterology 2017; 52(2): 164 doi: 10.1007/s00535-016-1264-3
150
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
151
Lindsey Kennedy, Heather Francis, Gianfranco Alpini. Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine. Cellular and Molecular Gastroenterology and Hepatology 2022; 14(1): 236 doi: 10.1016/j.jcmgh.2022.04.004
152
Ramesh Kumar, Shantam Mohan. Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00068
153
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
154
Boren Jiang, Yingchao Chen, Kun Zhou, Yanjun Zheng, Yi Chen, Qin Li, Chunfang Zhu, Fangzhen Xia, Ting Gu, Yuyu Guo, Yingli Lu. Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. Obesity 2019; 27(5): 707 doi: 10.1002/oby.22432
155
Alexandra Feldman, Sebastian K Eder, Thomas K Felder, Lyudmyla Kedenko, Bernhard Paulweber, Andreas Stadlmayr, Ursula Huber-Schönauer, David Niederseer, Felix Stickel, Simon Auer, Elisabeth Haschke-Becher, Wolfgang Patsch, Christian Datz, Elmar Aigner. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. American Journal of Gastroenterology 2017; 112(1): 102 doi: 10.1038/ajg.2016.318
156
Katsuhisa Omagari, Masako Suzuta, Asami Taniguchi, Risa Kumamoto, Yuko Koyama, Ayumi Fukuda, Kazuhito Suruga, Mayuko Ichimura-Shimizu, Koichi Tsuneyama. A non-obese, diet-induced animal model of nonalcoholic steatohepatitis in Wistar/ST rats compared to Sprague-Dawley rats. Clinical Nutrition Experimental 2020; 30: 1 doi: 10.1016/j.yclnex.2020.03.001
157
Dimitrios Oikonomou, Georgios Georgiopoulos, Vassiliki Katsi, Chris Kourek, Constantinos Tsioufis, Alexendra Alexopoulou, Evaggelia Koutli, Dimitrios Tousoulis. Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?. European Journal of Gastroenterology & Hepatology 2018; 30(9): 979 doi: 10.1097/MEG.0000000000001191
158
Chen-Yuan Chiu, Tsai-En Yen, Shing-Hwa Liu, Meng-Tsan Chiang. Comparative Effects and Mechanisms of Chitosan and Its Derivatives on Hypercholesterolemia in High-Fat Diet-Fed Rats. International Journal of Molecular Sciences 2019; 21(1): 92 doi: 10.3390/ijms21010092
159
Kentaro Oniki. Multifaceted Clinical Research on Obesity-related Disease Prevention Focusing on the <i>DsbA-L</i> Gene. YAKUGAKU ZASSHI 2022; 142(11): 1177 doi: 10.1248/yakushi.22-00128
160
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Ulf Hammar, Per Stål, Rolf Hultcrantz, Stergios Kechagias. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study. Hepatology Communications 2018; 2(1): 48 doi: 10.1002/hep4.1124
161
Qiyue Wang, Wu Xue, Xiaoke Zhang, Fang Jin, James Hahn. S2FLNet: Hepatic steatosis detection network with body shape. Computers in Biology and Medicine 2022; 140: 105088 doi: 10.1016/j.compbiomed.2021.105088
162
Qianli Yuan, Huai Wang, Pei Gao, Weixin Chen, Min Lv, Shuang Bai, Jiang Wu. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China. International Journal of Environmental Research and Public Health 2022; 19(4): 2096 doi: 10.3390/ijerph19042096
163
Yuan Xie, Shaoqing Li, Rourou Chen, Rongbo He, Li Qian, Jing Zou, Yan Luo, Ying Zhang, Minjun Ji, Yu Liu. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver. Metabolic Syndrome and Related Disorders 2022; 20(8): 451 doi: 10.1089/met.2021.0090
164
Lampros Chrysavgis, Eleftheria Ztriva, Adonis Protopapas, Konstantinos Tziomalos, Evangelos Cholongitas. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World Journal of Gastroenterology 2020; 26(42): 6514-6528 doi: 10.3748/wjg.v26.i42.6514
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345